Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Personal Products Industry Analysis

UpdatedAug 10, 2026
DataAggregated Company Financials
Companies104
  • 7D3.2%
  • 3M11.6%
  • 1Y-11.0%
  • YTD-2.4%

In the last week, the Personal Products industry is up 3.2%, with Estée Lauder Companies up 4.3%. In the same time, BellRing Brands was down 11%. In contrast, the industry has lost 11% in the last 12 months. Earnings are forecast to grow by 30% annually.

Industry Valuation and Performance

Has the U.S. Personal Products Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 10 Aug 2026US$87.6bUS$48.1bUS$711.1m15.5x123.1x1.8x
Wed, 08 Jul 2026US$86.3bUS$47.9bUS$708.8m19.2x121.7x1.8x
Fri, 05 Jun 2026US$76.9bUS$48.3bUS$699.1m16.8x110x1.6x
Sun, 03 May 2026US$78.8bUS$48.1bUS$614.4m22.4x128.3x1.6x
Tue, 31 Mar 2026US$73.8bUS$48.2bUS$671.5m20.7x109.9x1.5x
Thu, 26 Feb 2026US$98.3bUS$48.2bUS$862.3m22.8x114x2x
Sat, 24 Jan 2026US$97.6bUS$47.6bUS$350.1m22.8x278.8x2x
Mon, 22 Dec 2025US$90.9bUS$47.6bUS$351.6m22.8x258.5x1.9x
Wed, 19 Nov 2025US$80.6bUS$47.6bUS$558.6m21.7x144.3x1.7x
Fri, 17 Oct 2025US$91.0bUS$47.7bUS$307.8m19.1x295.5x1.9x
Sun, 14 Sep 2025US$94.1bUS$47.6bUS$304.1m21.2x309.3x2x
Tue, 12 Aug 2025US$98.8bUS$48.1bUS$562.3m20.1x175.8x2.1x
Thu, 10 Jul 2025US$98.5bUS$48.0bUS$109.5m18x899.6x2.1x
Sat, 07 Jun 2025US$93.8bUS$48.0bUS$127.3m17.2x737.3x2x
Mon, 05 May 2025US$91.3bUS$48.3bUS$374.3m21.2x244x1.9x
Wed, 02 Apr 2025US$91.7bUS$48.7bUS$556.6m24.8x164.7x1.9x
Fri, 28 Feb 2025US$95.6bUS$49.0bUS$328.5m26.4x290.9x2x
Sun, 26 Jan 2025US$98.5bUS$49.3bUS$1.5b25.5x66.8x2x
Tue, 24 Dec 2024US$98.4bUS$49.3bUS$1.5b27.4x66.7x2x
Thu, 21 Nov 2024US$98.2bUS$49.3bUS$1.5b27x67x2x
Sat, 19 Oct 2024US$103.4bUS$49.5bUS$1.6b26.7x64x2.1x
Mon, 16 Sep 2024US$107.3bUS$49.5bUS$1.6b21.6x65.5x2.2x
Wed, 14 Aug 2024US$104.3bUS$49.2bUS$1.9b23.5x55.5x2.1x
Fri, 12 Jul 2024US$108.2bUS$49.0bUS$2.4b21.4x44.7x2.2x
Sun, 09 Jun 2024US$113.5bUS$49.0bUS$2.4b22.6x46.8x2.3x
Tue, 07 May 2024US$118.8bUS$48.7bUS$2.7b23.9x44.2x2.4x
Thu, 04 Apr 2024US$127.3bUS$48.8bUS$2.5b25.8x50.2x2.6x
Sat, 02 Mar 2024US$129.9bUS$49.0bUS$2.5b30.4x52.8x2.6x
Mon, 29 Jan 2024US$125.3bUS$50.1bUS$2.6b27.1x49.1x2.5x
Wed, 27 Dec 2023US$128.8bUS$49.9bUS$2.6b24.7x48.9x2.6x
Fri, 24 Nov 2023US$111.5bUS$50.0bUS$2.6b21.9x43.1x2.2x
Sun, 22 Oct 2023US$115.9bUS$50.0bUS$3.3b22.9x35.4x2.3x
Tue, 19 Sep 2023US$132.0bUS$50.0bUS$3.3b21.8x40.2x2.6x
Thu, 17 Aug 2023US$136.3bUS$49.8bUS$3.0b20.7x44.7x2.7x
Price to Earnings Ratio

44.7x


Total Market Cap: US$136.3bTotal Earnings: US$3.0bTotal Revenue: US$49.8bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Personal Products Industry Price to Earnings3Y Average 175.5x202420252026
Current Industry PE
  • Investors are pessimistic on the American Personal Products industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 123x which is lower than its 3-year average PE of 176x.
  • The 3-year average PS ratio of 2.1x is higher than the industry's current PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Personal Products industry have declined 38% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Consumer Staples industry?

US Market2.74%
Consumer Staples0.26%
Personal Products3.19%
Personal Products3.19%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
EL Estée Lauder CompaniesUS$88.354.3%
+US$1.3b		-0.9%PS2.2x
ELF e.l.f. BeautyUS$98.4919.2%
+US$941.1m		-11.8%PE97.5x
KVUE KenvueUS$19.231.2%
+US$437.1m		-9.4%PE22.3x
HNST Honest CompanyUS$5.4649.0%
+US$182.3m		36.5%PS1.7x
EPC Edgewell Personal CareUS$28.382.9%
+US$36.6m		28.8%PS0.6x

Latest News

BRBR
US$11.56
BellRing Brands
7D
-10.7%
1Y
-70.2%
HNST
US$5.46
Honest Company
7D
49.0%
1Y
36.5%
Narrative Update • Aug 09

HNST: Rising Q2 Optimism And Tariff Reinvestment Will Ultimately Restrain Future Returns

Analysts now see higher fair value for Honest Company shares, with the average price target rising from $4 to about $4.82. This shift is supported by recent Q2 outperformance, higher earnings estimates, and an improved outlook for growth and profitability in higher margin categories.
IPAR
US$122.97
Interparfums
7D
-1.6%
1Y
6.9%
EPC
US$28.38
Edgewell Personal Care
7D
2.9%
1Y
28.8%
HLF
US$12.35
Herbalife
7D
-3.0%
1Y
38.6%
NATR
US$16.38
Nature's Sunshine Products
7D
-22.5%
1Y
1.7%
New Narrative • Aug 08

Digital Expansion And High Margins Will Support Long-Term Upside Potential

Catalysts About Nature's Sunshine Products Nature's Sunshine Products sells nutritional supplements under the Nature's Sunshine and Synergy brands through digital, direct selling and other channels across multiple regions. What are the underlying business or industry changes driving this perspective?
ELF
US$98.49
e.l.f. Beauty
7D
19.2%
1Y
-11.8%
KVUE
US$19.23
Kenvue
7D
1.2%
1Y
-9.4%
ODD
US$14.12
Oddity Tech
7D
-7.3%
1Y
-75.9%
MED
US$12.62
Medifast
7D
29.6%
1Y
-1.6%
Seeking Alpha • Aug 06

Medifast: Worth A Speculative Entry As Sales Stabilize (Rating Upgrade)

Summary Medifast, Inc. has started to report stabilizing sales through improved coach productivity, shown again in the Q2 report. Stabilized sales provide a pathway to stabilize earnings. MED targets profitability by Q4 already, but the target has to be taken with caution. Due to MED's $15.2 in net cash per share, the stock seems attractive. I estimate 44% upside to $18.8 on the condition that earnings improve near breakeven. Read the full article on Seeking Alpha
USNA
US$15.47
USANA Health Sciences
7D
-32.3%
1Y
-47.2%
Narrative Update • Aug 05

USNA: Index Additions Will Support Future Stock Upside Despite Impairment

Analysts have revised their price target on USANA Health Sciences to $25.00 from $39.00, citing updated assumptions for revenue growth, profit margins, the discount rate, and future P/E expectations. What’s in the News for USANA Health Sciences USANA Health Sciences reported an estimated preliminary non cash goodwill impairment charge of US$29 million for the second quarter ended July 4, 2026, reflecting recent performance, changes in near term forecasts, and updated valuation assumptions under accounting standards.
NAGE
US$3.12
Niagen Bioscience
7D
-11.6%
1Y
-68.2%
COTY
US$2.82
Coty
7D
1.1%
1Y
-40.3%
WALD
US$1.39
Waldencast
7D
-18.2%
1Y
-17.3%
EL
US$88.35
Estée Lauder Companies
7D
4.3%
1Y
-0.9%
NUS
US$5.49
Nu Skin Enterprises
7D
6.4%
1Y
-48.1%